Mar-amlodipine: Affected Lots May Contain Tablet(s) Of Midodrine 2.5mg Tablets.

Recall Summary Certain lots of MAR-AMLODIPINE tablets may contain Midodrine 2.5mg tablets instead of the amlodipine they should contain. This mix-up is a serious safety concern because patients would receive the wrong medication. The affected product has been distributed across Canada.

Product
MAR-AMLODIPINE
Reason
Product safety concern
Classification
Class I
Category
drug recall
Country
Canada
Agency
HC-DRUGS
Recall date
2026-02-09
Status
Ongoing
Distribution
Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/ae559b7b-b973-48c2-b4d3-96a1a01ad051